-
1 week ago | 
thepointsguy.com | Ethan Steinberg |Daisy Hernandez |Daisy Hernández
The cards we feature here are from partners who compensate us when you are approved through our site, and this may impact how or where these products appear. We don’t cover all available credit cards, but our analysis, reviews, and opinions are entirely from our editorial team. Terms apply to the offers listed on this page. Please view our advertising policy and product review methodology for more information.
-
1 week ago | 
asreport.americanbanker.com | Ethan Steinberg |Ayai Tomisawa |Takahiko Hyuga
(Bloomberg) -- European and Asian money managers are showing signs of losing some of their appetite for lending to US companies as trade wars heat up, in a potentially worrying sign for corporate America. Investors outside the US turned into net sellers of corporate debt in the first half of April, after US President Donald Trump announced the highest tariffs on foreign countries in more than a century. That's according to data tracking direct flows compiled by Goldman Sachs Group Inc.
-
2 weeks ago | 
news.bloombergtax.com | Ethan Steinberg |Dan Wilchins
S&P Global Inc., a company that rates bonds and sells market data, said it expects to bring in less revenue than originally forecast this year, as on-again, off-again tariff policies spur market tumult and cause companies to delay debt sales.
-
2 weeks ago | 
bloomberglinea.com | Ethan Steinberg |Mark Kauzlarich
Bloomberg — Johnson & Johnson (JNJ), una de las pocas empresas que quedan con una calificación crediticia superior, ya no corre el riesgo de una rebaja, dijo el viernes S&P Global Ratings. El fabricante de Tylenol, así como de los medicamentos de prescripción más vendidos, fue afirmado en AAA, el nivel más alto, por S&P. La firma calificadora citó las “políticas financieras muy conservadoras” de la dirección, al retirar a la empresa de la vigilancia de un recorte.
-
3 weeks ago | 
bloomberglinea.com | Ethan Steinberg |Jeenah Moon
Bloomberg — Moody’s Corp. (MCO) rebajó sus previsiones de ganancias para el año mientras la firma se prepara para más oscilaciones del mercado como las que han sacudido incluso el relativamente plácido mundo de la deuda corporativa. La empresa de calificación y análisis rebajó sus beneficios por acción ajustados para todo el año entre 13,25 y 14 dólares, frente a un rango previsto anteriormente de entre 14 y 14,50 dólares. Moody’s citó el aumento de la volatilidad en un comunicado.
-
3 weeks ago | 
thepointsguy.com | Ethan Steinberg |Ben Smithson
The cards we feature here are from partners who compensate us when you are approved through our site, and this may impact how or where these products appear. We don’t cover all available credit cards, but our analysis, reviews, and opinions are entirely from our editorial team. Terms apply to the offers listed on this page. Please view our advertising policy and product review methodology for more information.
-
1 month ago | 
thepointsguy.com | Ethan Steinberg |Ben Smithson |Rachel Craft
The cards we feature here are from partners who compensate us when you are approved through our site, and this may impact how or where these products appear. We don’t cover all available credit cards, but our analysis, reviews, and opinions are entirely from our editorial team. Terms apply to the offers listed on this page. Please view our advertising policy and product review methodology for more information. This is a recurring post, regularly updated with the latest information.
-
2 months ago | 
treasuryandrisk.com | Ethan Steinberg |Josh Wingrove |Amara Omeokwe |Catarina Saraiva
A Ford dealership in Montreal, Quebec, on February 27, 2025. Credit: Andrej Ivanov/Bloomberg. Bond investors are getting a little more concerned about the outlook for automakers that could see their bottom lines hit by U.S. tariffs. The extra yield that bondholders get for owning investment-grade car bonds instead of Treasuries has widened about 0.2 percentage point since the end of January.
-
2 months ago | 
news.bloombergtax.com | Ethan Steinberg |Hannah Benjamin-Cook |Caleb Mutua
Johnson & Johnson sold $5 billion of high-grade corporate bonds Tuesday to help fund its acquisition of Intra-Cellular Therapies Inc., part of the market’s second-busiest day this year. The drug and medical-devices maker sold dollar-denominated notes in five parts, according to a person familiar with the matter who asked not to be identified as the details are private.
-
Feb 12, 2025 | 
business-standard.com | Josyana Joshua |Ethan Steinberg
The Trump administration's moves to trim government spending pose a short-term "understated risk" for companies all across the corporate credit market, according to a Barclays Plc analysis. The efforts, led by Elon Musk's Department of Government Efficiency, have sparked concern about companies with federal contract exposure, analysts led by Dominique Toublan wrote in a note Wednesday.
